Thursday, November 15, 2012
Print Current Session:
|
|
Thursday
SESSION 19:
CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2012: WHERE IS IT AND WHERE IS IT GOING
Moderators:Giorgio M. Biasi, MD / Frank J. Veith, MD
|
|
SESSION 19 SCHEDULE | |
2:12 PM - 2:17 PM | Why MRI Should Be Done Before All Revascularization Procedures (CAS And CEA): Duplex Is Not Enough |
Presenter(s):Emmanuel M. Houdart, MD | |
2:18 PM - 2:23 PM | Closed vs. Open Cell Stents For CAS: The Number Of Embolic Particles Are No Greater Nor Are Outcomes Worse With Open Cell Stents |
Presenter(s):Peter L. Faries, MD, FACS | |
2:24 PM - 2:29 PM | CAS For Total Carotid Occlusion: It Can Work And Be Beneficial: Under What Circumstances |
Presenter(s):Paul H.L. Kao, MD | |
2:30 PM - 2:35 PM | DEBATE: CAS Is Good Treatment For Most Patients With Symptomatic And Asymptomatic Carotid Stenosis |
Presenter(s):Klaus D. Mathias, MD | |
2:36 PM - 2:41 AM | DEBATE: CAS Is Not Good Treatment For Most Patients With Symptomatic And Asymptomatic Carotid Stenosis |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Abstract | |
2:42 PM - 2:47 PM | Is Current Best Medical Treatment (BMT) Feasible And Does It Work To Decrease Strokes From Intracranial Disease In A High Risk Population: Results From The SAMMPRIS Trial Suggest BMT Can Decrease Strokes Markedly |
Presenter(s):Marc Chimowitz, MD | |
2:48 PM - 2:53 PM | Analysis Of CREST By A Neuroradiologist: What Is The Significance Of A Minor Stroke |
Presenter(s):Emmanuel M. Houdart, MD | |
2:54 PM - 2:59 PM | DEBATE: Cardiac Events Are An Appropriate End-Point For Evaluating CAS vs. CEA Outcomes; And In CREST, CAS Results Improved With Time |
Presenter(s):William A. Gray, MD | |
3:00 PM - 3:05 PM | DEBATE: Cardiac Events Are Not An Appropriate End-Point For Evaluating CAS vs. CEA Outcomes; And In CREST, CAS Results Did Not Improve With Time |
Presenter(s):Wesley S. Moore, MD | |
View Abstract | |
3:06 PM - 3:11 PM | Interventions Performed Within 1 Week Of A Neurological Event: Outcomes Of CEA Are Better Than CAS |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
3:12 PM - 3:17 PM | The Case Against Embolic Protection Devices In CAS: Why Therefore Are They So Widely Used |
Presenter(s):Michel S. Makaroun, MD | |
3:18 PM - 3:23 PM | Meta-Analysis Of CAS By Cervical Access Shows Dramatic Reduction In Neurological Events |
Presenter(s):Patrice F. Bergeron, MD / Petrosian Andranik, MD | |
3:24 PM - 3:29 PM | A Specialized Device For Performing CAS Via A Cervical Approach With Flow Reversal (FAST-CAS System): Early Results From The PROOF Trial |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
3:30 PM - 3:35 PM | DEBATE: Why Is It Difficult To Randomize Asymptomatic Carotid Stenosis Patients To A 3-Armed Trial: CEA vs. CAS vs. BMT |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
3:36 PM - 3:41 PM | DEBATE:Why We Must Have A Trial Comparing BMT To CAS And CEA In Asymptomatic Patients With Carotid Stenosis |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP, FRACP | |
View Abstract | |
3:42 PM - 3:47 PM | TCD Embolic Signals, Silent Infarcts On CT-Brain Scans, Or The Size Of Juxtaluminal Black Area In Evaluating Stroke Potential Of Asymptomatic Carotid Lesions |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Abstract | |
3:48 PM - 4:00 PM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 19 | |
previous | next |